Annals of internal medicine
-
Comment Meta Analysis
In type 2 diabetes, SGLT2 inhibitors reduced risk for serious hyperkalemia without increasing hypokalemia.
Neuen BL, Oshima M, Agarwal R, et al. Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials. Circulation. 2022;145:1460-70. 35394821.
-
Review Meta Analysis
A Framework for the Development of Living Practice Guidelines in Health Care.
Living practice guidelines are increasingly being used to ensure that recommendations are responsive to rapidly emerging evidence. ⋯ None.
-
Comment Meta Analysis
In diabetes, some statins reduce non-HDL-C better than others vs. placebo.
Hodkinson A, Tsimpida D, Kontopantelis E, et al. Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis. BMJ. 2022;376:e067731. 35331984.
-
Comment Meta Analysis
In HF, SGLT2 inhibitors reduce HF hospitalizations at up to 2 y.
Zou X, Shi Q, Vandvik PO, et al. Sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a systematic review and meta-analysis. Ann Intern Med. 2022;175:851-61. 35404670.
-
Review Meta Analysis
Effectiveness and Harms of Contraceptive Counseling and Provision Interventions for Women : A Systematic Review and Meta-analysis.
The effectiveness and harms of contraceptive counseling and provision interventions are unclear. ⋯ Resources Legacy Fund. (PROSPERO: CRD42020192981).